Special Drug Use-results Survey for Long-term Use (Fostamatinib)

Recruiting now

Conditions studied: Chronic Idiopathic Thrombocytopenic Purpura

In brief

The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.

Key facts

Study ID

NCT06757257

Run by

Kissei Pharmaceutical Co., Ltd.

People needed

149

Starts

2023-05-29

Expected to finish

2028-09-30

Last updated by the study team

2025-01-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.

Where it is running

• Research site — Tokyo and Japanese Other Cities, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.